A biomarker for early Type 2 diabetes

Genetic analyses suggest that branched chain amino acids may be a sensitive biomarker of early or subclinical Type 2 diabetes and could be used to identify risk and implement preventive measures.

Study shows liraglutide results in increased insulin sensitivity independent of weight loss

Study links gene network and pancreatic beta cell defects to Type 2 diabetes

A comprehensive study that integrates multiple analytic approaches has linked a regulatory gene network and functional defects in insulin-producing pancreatic beta cells to Type 2 diabetes.

Ashcroft named to receive Vanderbilt Prize in Biomedical Science

Professor Dame Frances Ashcroft, a British physiologist known internationally for her work on insulin secretion, Type 2 diabetes and neonatal diabetes, is the recipient of the 2023 Vanderbilt Prize in Biomedical Science.

Diabetes drug may improve asthma

New biomarker finding strengthens the case for using GLP-1R agonists to treat patients with Type 2 diabetes who also suffer from asthma.

Metabolic signatures of Type 2 diabetes risk

Vanderbilt epidemiologists found 32 blood metabolites associated with obesity and showed that adding these to traditional disease prediction models improves accuracy of determining Type 2 diabetes risk.